Skip to content
Silver Vision Lab

The Zimbabwean Government Declines ‘One-Sided’ US Healthcare Assistance Deal Due to Data Concerns

Health funding illustration
The offered US financial assistance was intended for programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has rejected a substantial US healthcare agreement worth $367m (£272m) over five years over Washington's insistence on confidential biological samples.

This move came to light after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "lopsided".

A government representative has since clarified that the United States was seeking health data for research and commercial purposes but was not willing to guarantee the benefits from future medical innovations.

"We are forced to start the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for further dialogue to reach a deal suitable to both sides so the nation's critical HIV treatment initiative can proceed.

Wider Background

This rejection comes after a comparable situation in neighbouring Kenya, where a high court halted a related deal with the US after concerns were filed about the safety of citizens' health data.

Since returning to the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

The agency had overseen aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance openness and accountability.

According to reports, Sixteen nations in Africa have to date signed these new agreements, constituting more than $18.3bn in committed funds.

Specifics of the Rejected Agreement

The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," Tremont said.

However, government spokesperson Nick Mangwana said the arrangement was "unequal".

"Our nation was requested to surrender its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," Mangwana explained.

"Put simply, our nation would provide the raw materials for medical research without any assurance that the resulting innovations would be accessible to our citizens should a new health crisis emerge."

National Interest and International Frameworks

Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems already set up via the global organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with potential pandemics.

"This framework is designed to guarantee that when a nation contributes its data, the benefits – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We encourage further discussions with our American counterparts on how subsequent co-operation might be designed in a way that honours the independence and dignity of both nations."

Medical Community Reaction

Medical experts stated it understood the government's concerns, but urged that negotiations need to persist given that much of the country's Aids initiatives were funded by international support.

"Where specific concerns exist, such as those relating to data governance or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," the group said.

The situation highlights the continuing tensions between accepting vital international aid and protecting national sovereignty in an ever more data-driven world.

About the author

Denise Brooks

AI researcher and tech enthusiast exploring machine learning and its societal impact.

Silver Vision Lab

Type to search articles.